KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-01
DOI
10.1111/jcmm.18020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surgical Management of Gastric Cancer
- (2022) George Z. Li et al. JAMA Surgery
- PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
- (2022) Yan Peng et al. Frontiers in Oncology
- Novel Drugs with High Efficacy against Tumor Angiogenesis
- (2022) Shiyu Qi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrated screens uncover a cell surface tumor suppressor gene KIRREL involved in Hippo pathway
- (2022) Chao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current treatment and recent progress in gastric cancer
- (2021) Smita S. Joshi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
- (2021) Wei Cao et al. CHINESE MEDICAL JOURNAL
- Insulin and the insulin receptor collaborate to promote human gastric cancer
- (2021) Marina Saisana et al. Gastric Cancer
- Phosphorylation of slit diaphragm proteins NEPHRIN and NEPH1 upon binding of HGF promotes podocyte repair
- (2021) Ashish K. Solanki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
- (2021) Feng‐Hua Wang et al. Cancer Communications
- VEGF inhibition in urothelial cancer: the past, present and future
- (2020) Sanaz Ghafouri et al. WORLD JOURNAL OF UROLOGY
- Overexpression of kin of IRRE-Like protein 1 (KIRREL) as a prognostic biomarker for breast cancer
- (2020) Kexin Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Gastric cancer: a comprehensive review of current and future treatment strategies
- (2020) Rachel E. Sexton et al. CANCER AND METASTASIS REVIEWS
- First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
- (2020) Hyun Cheol Chung et al. Future Oncology
- Vessel co-option in cancer
- (2019) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- Disruption of the exocyst induces podocyte loss and dysfunction
- (2019) Deepak Nihalani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Updates on Management of Gastric Cancer
- (2019) Fabian M. Johnston et al. Current Oncology Reports
- Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
- (2019) Raluca Ioana Teleanu et al. Journal of Clinical Medicine
- Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
- (2018) Jin Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- (2018) Kabir A. Khan et al. Nature Reviews Clinical Oncology
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of Kin of IRRE-Like Protein 1 (KIRREL) in Gastric Cancer and Its Clinical Prognostic Significance
- (2018) Ming-Jun Zhang et al. MEDICAL SCIENCE MONITOR
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
- (2017) Pol Gimenez-Xavier et al. MOLECULAR CANCER THERAPEUTICS
- CpG methylation patterns are associated with gene expression variation in osteosarcoma
- (2017) Qiang Wang Molecular Medicine Reports
- Progress in the treatment of advanced gastric cancer
- (2017) Zheyu Song et al. TUMOR BIOLOGY
- Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials
- (2016) Fei Shan et al. CANCER LETTERS
- Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
- (2016) Jason S. L. Yu et al. DEVELOPMENT
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation
- (2016) Marina Saisana et al. Oncotarget
- Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer
- (2016) Youliang Wu et al. Oncotarget
- CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer
- (2015) Zhe-Wei Wei et al. CANCER LETTERS
- Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing
- (2015) Charles Walther et al. LABORATORY INVESTIGATION
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation
- (2015) Peter W. Hewett et al. THROMBOSIS AND HAEMOSTASIS
- Signal Transduction in Cancer
- (2015) R. Sever et al. Cold Spring Harbor Perspectives in Medicine
- PI3K/AKT signaling pathway and cancer: an updated review
- (2014) Miriam Martini et al. ANNALS OF MEDICINE
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance
- (2014) Oscar Tapia et al. VIRCHOWS ARCHIV
- Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
- (2014) Vladimir Riabov et al. Frontiers in Physiology
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Cancer prevention by targeting angiogenesis
- (2012) Adriana Albini et al. Nature Reviews Clinical Oncology
- An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
- (2011) M. Moehler et al. EUROPEAN JOURNAL OF CANCER
- Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203
- (2010) Weijing Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm
- (2008) Helen Weavers et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now